SOFTCARE (02698) Posts Interim Results with Adjusted Net Profit of $78.605 Million, Up 53.14% Year-on-Year

Stock News
Aug 19

SOFTCARE (02698) has announced its interim results for fiscal 2026, reporting total revenue of $333 million, representing a year-on-year increase of 30.68%. The company's adjusted net profit reached $78.605 million, climbing 53.14% compared to the same period last year. Earnings per share stood at 12.2 US cents, with an interim dividend of 8 US cents per share proposed.

The group adheres to a consumer-centric business philosophy, with a strong focus on expanding its footprint in emerging markets across Africa and Latin America. Its core operating model, which combines localized production, a global supply chain, and deep distribution networks, remains a key competitive advantage.

During the period, the company continued to optimize its production capacity in key regions, including Africa and Latin America, while upgrading intelligent production lines and quality control systems. These initiatives have further cemented its leadership position in the hygiene products sector within emerging markets.

Leveraging a stable supply chain, efficient manufacturing capabilities, and cost-competitive products, the group has successfully capitalized on market opportunities. This strategic approach has laid a solid foundation for sustained growth, enabling the company to achieve steady expansion in both business scale and profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10